ArticleArchives of dermatological research2025
Elucidating the molecular association and potential mechanisms between psoriasis and atrial fibrillation through biomarker and immune infiltration analysis.
Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A systems-oriented Ayurvedic approach in chronic plaque psoriasis with renal inflammatory indicators: a 2-year longitudinal case report.Frontiers in medicine · 2026Article
- Psoriasis and atrial fibrillation: Exploring the intersection.World journal of experimental medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple studies have suggested that psoriasis may increase the risk of atrial fibrillation (AF). However, the molecular and immune mechanisms underlying this association remain unclear. This study initially downloaded gene expression profiles for psoriasis and AF from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) for both conditions were identified and hub genes were selected. Receiver operating characteristic (ROC) curve analysis and the prediction and validation of transcription factors (TFs) were conducted. Immune cell infiltration was analyzed using the CIBERSORT method. Mendelian randomization (MR) analysis was performed to explore the potential causal relationships between 731 Immunophenotypes and the risk of psoriasis and AF. A total of 1627 DEGs were identified from the psoriasis and AF datasets. Intersection analysis revealed 119 common DEGs. 10 potential biomarker hub genes, including GZMB, FCGR3B, LILRB2, IL7R, CD2, MYD88, NCF2, TLR2, GZMA, and CXCR2. ROC analysis showed that the area under the curve scores for the hub genes were 0.987 and 1.00 for psoriasis and AF, respectively. USF2, NFKB1 and RELA were predicted to be key TFs. Immune cell infiltration analysis indicated significant differences in T cell follicular helper, T cell gamma delta, and monocytes in the two diseases. MR analysis revealed 28 Immunophenotypes potentially associated with psoriasis risk and 18 traits potentially associated with AF risk. Notably, HLA DR + Natural Killer and CD39 on granulocyte cells were identified as influencing the risk of both diseases. This study preliminarily identified biomarkers and explored the molecular mechanisms of psoriasis and AF, highlighting immune cells potentially associated with disease pathogenesis. These findings provide a scientific basis for developing new diagnostic and therapeutic strategies, aiding in better prevention and management of AF risk in psoriasis patients.
Indexed as
Identifiers
39776247What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.